 Christopher Evans
Concepts (471)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucins | 22 | 2024 | 61 | 4.090 |
Why?
| | Mucus | 14 | 2024 | 54 | 3.620 |
Why?
| | Mucin-5B | 23 | 2024 | 184 | 2.860 |
Why?
| | Mucin 5AC | 17 | 2024 | 48 | 2.280 |
Why?
| | Lung | 36 | 2021 | 3595 | 2.120 |
Why?
| | Mucociliary Clearance | 7 | 2021 | 42 | 1.950 |
Why?
| | Respiratory Mucosa | 17 | 2024 | 251 | 1.720 |
Why?
| | Lung Diseases, Obstructive | 3 | 2023 | 40 | 1.710 |
Why?
| | Idiopathic Pulmonary Fibrosis | 12 | 2022 | 510 | 1.360 |
Why?
| | Expectorants | 4 | 2023 | 24 | 1.260 |
Why?
| | Asthma | 9 | 2024 | 2051 | 1.150 |
Why?
| | Bronchial Hyperreactivity | 5 | 2015 | 95 | 0.980 |
Why?
| | Vagus Nerve | 4 | 2023 | 81 | 0.940 |
Why?
| | Bronchioles | 4 | 2024 | 22 | 0.890 |
Why?
| | Quantum Dots | 3 | 2012 | 35 | 0.870 |
Why?
| | Animals | 62 | 2024 | 31867 | 0.870 |
Why?
| | Reflex | 1 | 2023 | 65 | 0.840 |
Why?
| | Respiratory System | 6 | 2020 | 138 | 0.830 |
Why?
| | Mice | 43 | 2024 | 14927 | 0.800 |
Why?
| | Disulfides | 2 | 2022 | 90 | 0.770 |
Why?
| | Respiratory Hypersensitivity | 1 | 2021 | 60 | 0.740 |
Why?
| | Homeostasis | 6 | 2020 | 578 | 0.730 |
Why?
| | Alveolar Epithelial Cells | 2 | 2019 | 96 | 0.720 |
Why?
| | Lung Injury | 2 | 2021 | 198 | 0.670 |
Why?
| | Disease Models, Animal | 17 | 2022 | 3545 | 0.610 |
Why?
| | Mice, Transgenic | 14 | 2020 | 1955 | 0.600 |
Why?
| | Mice, Inbred C57BL | 27 | 2022 | 4718 | 0.600 |
Why?
| | Eosinophilia | 1 | 2020 | 186 | 0.600 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 9 | 2022 | 928 | 0.600 |
Why?
| | Hypersensitivity | 1 | 2021 | 256 | 0.570 |
Why?
| | Epithelial Cells | 10 | 2019 | 956 | 0.560 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2018 | 72 | 0.550 |
Why?
| | Receptors, Muscarinic | 4 | 2001 | 18 | 0.530 |
Why?
| | Selenium Compounds | 2 | 2012 | 21 | 0.520 |
Why?
| | Chalcogens | 2 | 2012 | 3 | 0.510 |
Why?
| | Cadmium Compounds | 2 | 2012 | 30 | 0.510 |
Why?
| | Pulmonary Alveoli | 3 | 2016 | 374 | 0.500 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 464 | 0.480 |
Why?
| | Macrophages | 3 | 2016 | 1267 | 0.470 |
Why?
| | Inflammation | 11 | 2022 | 2485 | 0.440 |
Why?
| | Lung Diseases | 2 | 2018 | 703 | 0.440 |
Why?
| | Eosinophils | 4 | 2021 | 281 | 0.430 |
Why?
| | Lung Neoplasms | 5 | 2018 | 2201 | 0.430 |
Why?
| | Cadmium | 1 | 2012 | 58 | 0.410 |
Why?
| | Cystic Fibrosis | 7 | 2021 | 957 | 0.410 |
Why?
| | Mice, Inbred BALB C | 8 | 2021 | 1153 | 0.410 |
Why?
| | Surface-Active Agents | 1 | 2012 | 79 | 0.400 |
Why?
| | Immunity, Innate | 5 | 2019 | 723 | 0.400 |
Why?
| | Intracellular Space | 1 | 2012 | 68 | 0.390 |
Why?
| | Promoter Regions, Genetic | 8 | 2018 | 1133 | 0.380 |
Why?
| | Uteroglobin | 5 | 2010 | 16 | 0.380 |
Why?
| | Ribonucleases | 3 | 2000 | 52 | 0.370 |
Why?
| | Organoselenium Compounds | 1 | 2010 | 11 | 0.360 |
Why?
| | Transcription Factors | 1 | 2018 | 1531 | 0.360 |
Why?
| | Bronchi | 3 | 2016 | 243 | 0.350 |
Why?
| | Cilia | 4 | 2022 | 162 | 0.350 |
Why?
| | Exocytosis | 3 | 2019 | 89 | 0.340 |
Why?
| | Humans | 45 | 2024 | 115038 | 0.320 |
Why?
| | Mucous Membrane | 4 | 2021 | 108 | 0.320 |
Why?
| | Intestinal Mucosa | 3 | 2022 | 528 | 0.310 |
Why?
| | Airway Obstruction | 2 | 2016 | 168 | 0.300 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2011 | 799 | 0.280 |
Why?
| | Alveolitis, Extrinsic Allergic | 2 | 2022 | 92 | 0.270 |
Why?
| | Ovalbumin | 7 | 2015 | 162 | 0.270 |
Why?
| | Munc18 Proteins | 2 | 2019 | 23 | 0.270 |
Why?
| | Gene Expression | 4 | 2018 | 1423 | 0.260 |
Why?
| | Anti-Inflammatory Agents | 2 | 2015 | 451 | 0.250 |
Why?
| | Colloids | 3 | 2019 | 56 | 0.240 |
Why?
| | Phagocytosis | 3 | 2016 | 352 | 0.240 |
Why?
| | Mice, Knockout | 12 | 2019 | 2585 | 0.240 |
Why?
| | Th2 Cells | 4 | 2017 | 155 | 0.230 |
Why?
| | Female | 31 | 2021 | 59610 | 0.230 |
Why?
| | Energy Metabolism | 2 | 2024 | 729 | 0.230 |
Why?
| | Bronchoalveolar Lavage Fluid | 6 | 2022 | 590 | 0.220 |
Why?
| | Gene Expression Regulation | 5 | 2018 | 2329 | 0.220 |
Why?
| | MicroRNAs | 3 | 2019 | 603 | 0.210 |
Why?
| | Glycolysis | 1 | 2024 | 227 | 0.210 |
Why?
| | Salts | 1 | 2023 | 35 | 0.210 |
Why?
| | Glycosyltransferases | 1 | 2022 | 13 | 0.210 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2022 | 11 | 0.210 |
Why?
| | Genetic Predisposition to Disease | 5 | 2018 | 2108 | 0.210 |
Why?
| | Bronchiectasis | 1 | 2024 | 107 | 0.210 |
Why?
| | Saccharopolyspora | 1 | 2022 | 6 | 0.210 |
Why?
| | Receptor, Muscarinic M2 | 5 | 2005 | 8 | 0.210 |
Why?
| | Glycoproteins | 2 | 2022 | 305 | 0.210 |
Why?
| | Golgi Apparatus | 1 | 2022 | 89 | 0.200 |
Why?
| | Haemophilus influenzae | 4 | 2010 | 48 | 0.200 |
Why?
| | Colon | 2 | 2022 | 233 | 0.200 |
Why?
| | Immunohistochemistry | 4 | 2015 | 1634 | 0.200 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 347 | 0.190 |
Why?
| | Sulfhydryl Compounds | 1 | 2023 | 177 | 0.190 |
Why?
| | Pulmonary Eosinophilia | 1 | 2001 | 26 | 0.190 |
Why?
| | Metaplasia | 5 | 2008 | 54 | 0.190 |
Why?
| | Pseudomonas Infections | 2 | 2020 | 186 | 0.190 |
Why?
| | Leukocyte Count | 1 | 2021 | 292 | 0.180 |
Why?
| | Substance P | 1 | 2000 | 44 | 0.180 |
Why?
| | Blood Proteins | 3 | 2000 | 233 | 0.180 |
Why?
| | Mustard Gas | 1 | 2021 | 117 | 0.170 |
Why?
| | Male | 22 | 2021 | 55729 | 0.170 |
Why?
| | Antigens | 4 | 2007 | 318 | 0.170 |
Why?
| | Chemical Warfare Agents | 1 | 2021 | 120 | 0.170 |
Why?
| | Hypoxia | 2 | 2017 | 958 | 0.170 |
Why?
| | Syndecan-1 | 1 | 2019 | 27 | 0.170 |
Why?
| | Fibroblasts | 1 | 2024 | 839 | 0.170 |
Why?
| | Allergens | 2 | 2015 | 417 | 0.170 |
Why?
| | Gene Targeting | 2 | 2018 | 75 | 0.170 |
Why?
| | Lymphocyte Subsets | 1 | 2019 | 79 | 0.170 |
Why?
| | Butadienes | 2 | 2009 | 31 | 0.170 |
Why?
| | Orthomyxoviridae Infections | 1 | 2019 | 54 | 0.160 |
Why?
| | Polystyrenes | 2 | 2009 | 36 | 0.160 |
Why?
| | Colitis, Ulcerative | 1 | 2020 | 105 | 0.160 |
Why?
| | Interleukin-13 | 3 | 2019 | 123 | 0.160 |
Why?
| | Dexamethasone | 1 | 2001 | 317 | 0.160 |
Why?
| | Receptors, Interleukin-1 | 1 | 2020 | 227 | 0.160 |
Why?
| | Polymers | 1 | 2023 | 447 | 0.160 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 2 | 2018 | 42 | 0.160 |
Why?
| | Cysts | 1 | 2019 | 93 | 0.160 |
Why?
| | Bone Marrow Cells | 2 | 2017 | 267 | 0.160 |
Why?
| | Bleomycin | 4 | 2022 | 228 | 0.160 |
Why?
| | Signal Transduction | 8 | 2022 | 4525 | 0.160 |
Why?
| | Guinea Pigs | 5 | 2005 | 149 | 0.150 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 448 | 0.150 |
Why?
| | Extracellular Vesicles | 1 | 2019 | 83 | 0.150 |
Why?
| | Paraquat | 1 | 2018 | 14 | 0.150 |
Why?
| | Macrophage Activation | 1 | 2019 | 164 | 0.150 |
Why?
| | Herbicides | 1 | 2018 | 24 | 0.150 |
Why?
| | Colitis | 1 | 2020 | 226 | 0.150 |
Why?
| | Methacholine Chloride | 2 | 2015 | 47 | 0.150 |
Why?
| | Gene Expression Profiling | 4 | 2018 | 1523 | 0.150 |
Why?
| | Thrombospondin 1 | 1 | 2017 | 19 | 0.140 |
Why?
| | Schistosoma | 1 | 2017 | 18 | 0.140 |
Why?
| | Mast Cells | 2 | 2021 | 117 | 0.140 |
Why?
| | Bacteria | 3 | 2020 | 728 | 0.140 |
Why?
| | Transgenes | 1 | 2018 | 170 | 0.140 |
Why?
| | Neurons | 2 | 2005 | 1284 | 0.140 |
Why?
| | Mucin-2 | 1 | 2016 | 3 | 0.140 |
Why?
| | Leukocytes | 2 | 2016 | 277 | 0.140 |
Why?
| | Carcinogenesis | 1 | 2018 | 178 | 0.140 |
Why?
| | Cytokines | 6 | 2021 | 1843 | 0.140 |
Why?
| | Patient Outcome Assessment | 1 | 2018 | 122 | 0.140 |
Why?
| | Glucocorticoids | 1 | 2001 | 535 | 0.140 |
Why?
| | Bronchitis, Chronic | 1 | 2016 | 17 | 0.140 |
Why?
| | Survival Analysis | 3 | 2018 | 1211 | 0.140 |
Why?
| | Kartagener Syndrome | 1 | 2016 | 26 | 0.140 |
Why?
| | Bronchoconstriction | 2 | 2011 | 27 | 0.140 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 117 | 0.130 |
Why?
| | Glycosylation | 1 | 2016 | 131 | 0.130 |
Why?
| | Neutrophils | 3 | 2017 | 1164 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 351 | 0.130 |
Why?
| | Mutation | 5 | 2018 | 3350 | 0.130 |
Why?
| | Thiocyanates | 1 | 2015 | 29 | 0.130 |
Why?
| | Qc-SNARE Proteins | 1 | 2015 | 7 | 0.130 |
Why?
| | Qb-SNARE Proteins | 1 | 2015 | 6 | 0.130 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2015 | 48 | 0.130 |
Why?
| | Models, Biological | 2 | 2013 | 1636 | 0.130 |
Why?
| | Aspergillus oryzae | 1 | 2015 | 3 | 0.130 |
Why?
| | Deoxycytidine Kinase | 1 | 2014 | 3 | 0.120 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2014 | 5 | 0.120 |
Why?
| | Transcription, Genetic | 2 | 2018 | 1317 | 0.120 |
Why?
| | Cell Line | 4 | 2019 | 2645 | 0.120 |
Why?
| | Polysaccharides | 1 | 2014 | 78 | 0.120 |
Why?
| | Microbiota | 1 | 2021 | 648 | 0.110 |
Why?
| | Acute Lung Injury | 1 | 2017 | 300 | 0.110 |
Why?
| | Smoking | 2 | 2018 | 1392 | 0.110 |
Why?
| | Species Specificity | 1 | 2015 | 548 | 0.110 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 2715 | 0.110 |
Why?
| | Ear, Middle | 1 | 2013 | 89 | 0.110 |
Why?
| | Valerates | 1 | 2013 | 3 | 0.110 |
Why?
| | Adenosine Triphosphate | 3 | 2022 | 431 | 0.110 |
Why?
| | Bed Rest | 1 | 2013 | 15 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2015 | 386 | 0.110 |
Why?
| | Genes, Essential | 1 | 2012 | 19 | 0.100 |
Why?
| | Semiconductors | 1 | 2012 | 34 | 0.100 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 31 | 0.100 |
Why?
| | Muscle Development | 1 | 2013 | 98 | 0.100 |
Why?
| | Crystallization | 1 | 2012 | 136 | 0.100 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2012 | 49 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 928 | 0.100 |
Why?
| | Adenocarcinoma | 1 | 2018 | 795 | 0.100 |
Why?
| | Receptors, Immunologic | 1 | 2013 | 201 | 0.100 |
Why?
| | Polymerization | 1 | 2012 | 119 | 0.100 |
Why?
| | Bacterial Infections | 1 | 2013 | 219 | 0.100 |
Why?
| | Base Sequence | 3 | 2017 | 2119 | 0.100 |
Why?
| | Sarcopenia | 1 | 2013 | 63 | 0.100 |
Why?
| | Trichuris | 1 | 2011 | 3 | 0.100 |
Why?
| | Trichuriasis | 1 | 2011 | 4 | 0.100 |
Why?
| | Genes, ras | 2 | 2009 | 91 | 0.100 |
Why?
| | Sepsis | 1 | 2017 | 508 | 0.100 |
Why?
| | Intestinal Diseases, Parasitic | 1 | 2011 | 11 | 0.100 |
Why?
| | Antigens, Dermatophagoides | 1 | 2011 | 10 | 0.090 |
Why?
| | Integrases | 2 | 2010 | 116 | 0.090 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2011 | 58 | 0.090 |
Why?
| | Eosinophil Granule Proteins | 3 | 2000 | 20 | 0.090 |
Why?
| | Immune Tolerance | 1 | 2013 | 329 | 0.090 |
Why?
| | Acute Kidney Injury | 1 | 2017 | 638 | 0.090 |
Why?
| | Bronchial Provocation Tests | 2 | 2011 | 53 | 0.090 |
Why?
| | Phosphines | 1 | 2010 | 15 | 0.090 |
Why?
| | Th1 Cells | 1 | 2011 | 123 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2018 | 2799 | 0.090 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 963 | 0.090 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 385 | 0.090 |
Why?
| | Goblet Cells | 2 | 2020 | 16 | 0.090 |
Why?
| | Apoptosis | 3 | 2014 | 2366 | 0.090 |
Why?
| | Middle Aged | 7 | 2021 | 26826 | 0.090 |
Why?
| | DNA Primers | 2 | 2009 | 514 | 0.080 |
Why?
| | Proteins | 1 | 2015 | 915 | 0.080 |
Why?
| | Latex | 1 | 2009 | 9 | 0.080 |
Why?
| | Pentanes | 1 | 2009 | 9 | 0.080 |
Why?
| | Hemiterpenes | 1 | 2009 | 11 | 0.080 |
Why?
| | Curcumin | 1 | 2009 | 29 | 0.080 |
Why?
| | Dietary Supplements | 1 | 2013 | 458 | 0.080 |
Why?
| | Elastomers | 1 | 2009 | 25 | 0.080 |
Why?
| | Emulsions | 1 | 2009 | 43 | 0.080 |
Why?
| | Respiratory Function Tests | 2 | 2021 | 523 | 0.080 |
Why?
| | Immunoenzyme Techniques | 2 | 2010 | 192 | 0.080 |
Why?
| | Respiratory System Agents | 1 | 2008 | 22 | 0.080 |
Why?
| | Pneumococcal Infections | 1 | 2009 | 91 | 0.080 |
Why?
| | RNA, Messenger | 3 | 2017 | 2563 | 0.080 |
Why?
| | Electric Stimulation | 2 | 2000 | 261 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2017 | 1901 | 0.080 |
Why?
| | Cell Extracts | 1 | 2008 | 15 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2010 | 482 | 0.080 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2015 | 165 | 0.080 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2008 | 38 | 0.070 |
Why?
| | Gait | 1 | 2010 | 249 | 0.070 |
Why?
| | Recombination, Genetic | 1 | 2008 | 176 | 0.070 |
Why?
| | 3T3 Cells | 1 | 2007 | 140 | 0.070 |
Why?
| | PTEN Phosphohydrolase | 1 | 2008 | 140 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2010 | 676 | 0.070 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2009 | 299 | 0.070 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 206 | 0.070 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2009 | 370 | 0.070 |
Why?
| | Receptor, Adenosine A3 | 1 | 2006 | 1 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2007 | 218 | 0.070 |
Why?
| | Time Factors | 3 | 2011 | 6141 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 353 | 0.070 |
Why?
| | Walking | 1 | 2010 | 424 | 0.070 |
Why?
| | Gene Knockdown Techniques | 2 | 2017 | 299 | 0.070 |
Why?
| | Hypertension, Pulmonary | 1 | 2017 | 1736 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1477 | 0.070 |
Why?
| | Chemokines, CC | 1 | 2005 | 28 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2005 | 43 | 0.070 |
Why?
| | Adolescent | 2 | 2021 | 17862 | 0.060 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2008 | 311 | 0.060 |
Why?
| | Lung Diseases, Interstitial | 1 | 2011 | 515 | 0.060 |
Why?
| | Pseudomonas aeruginosa | 2 | 2018 | 299 | 0.060 |
Why?
| | rab3 GTP-Binding Proteins | 1 | 2004 | 2 | 0.060 |
Why?
| | Polyethylene Glycols | 1 | 2009 | 561 | 0.060 |
Why?
| | Aerosols | 3 | 2010 | 151 | 0.060 |
Why?
| | Pneumonia | 3 | 2017 | 568 | 0.060 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 529 | 0.060 |
Why?
| | Adult | 3 | 2021 | 30654 | 0.060 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 228 | 0.060 |
Why?
| | Up-Regulation | 1 | 2007 | 812 | 0.060 |
Why?
| | Transcriptome | 2 | 2019 | 725 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1477 | 0.060 |
Why?
| | Trachea | 2 | 2020 | 234 | 0.050 |
Why?
| | Age Factors | 1 | 2010 | 2894 | 0.050 |
Why?
| | Phenotype | 4 | 2014 | 2815 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 1990 | 0.050 |
Why?
| | Aging | 1 | 2013 | 1624 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 315 | 0.050 |
Why?
| | Mice, Mutant Strains | 2 | 2015 | 272 | 0.050 |
Why?
| | Ions | 1 | 2023 | 59 | 0.050 |
Why?
| | Diffusion | 1 | 2023 | 118 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2796 | 0.050 |
Why?
| | Fibrosis | 1 | 2024 | 454 | 0.050 |
Why?
| | Balantidiasis | 1 | 2001 | 1 | 0.050 |
Why?
| | Antibodies | 2 | 2000 | 372 | 0.050 |
Why?
| | ErbB Receptors | 2 | 2018 | 555 | 0.050 |
Why?
| | Mechlorethamine | 1 | 2021 | 64 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 172 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 752 | 0.050 |
Why?
| | Quinuclidines | 1 | 2000 | 4 | 0.050 |
Why?
| | Neurokinin-1 Receptor Antagonists | 1 | 2000 | 9 | 0.050 |
Why?
| | Protein Binding | 2 | 2017 | 1898 | 0.050 |
Why?
| | Dextran Sulfate | 1 | 2020 | 70 | 0.040 |
Why?
| | Neutrophil Infiltration | 2 | 2012 | 94 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 87 | 0.040 |
Why?
| | Respiration | 1 | 2021 | 182 | 0.040 |
Why?
| | Haemophilus Infections | 2 | 2010 | 28 | 0.040 |
Why?
| | Cell Proliferation | 3 | 2014 | 2191 | 0.040 |
Why?
| | Temperature | 1 | 2023 | 578 | 0.040 |
Why?
| | Cyclophosphamide | 1 | 2000 | 217 | 0.040 |
Why?
| | Trichinellosis | 1 | 2019 | 2 | 0.040 |
Why?
| | Trichinella spiralis | 1 | 2019 | 2 | 0.040 |
Why?
| | Cross Protection | 1 | 2019 | 4 | 0.040 |
Why?
| | Keratin-15 | 1 | 2019 | 12 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 744 | 0.040 |
Why?
| | Fluorescence | 1 | 2020 | 148 | 0.040 |
Why?
| | Surface Properties | 2 | 2012 | 387 | 0.040 |
Why?
| | Nippostrongylus | 1 | 2019 | 3 | 0.040 |
Why?
| | Strongylida Infections | 1 | 2019 | 6 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 1 | 2019 | 29 | 0.040 |
Why?
| | Histamine | 1 | 1999 | 65 | 0.040 |
Why?
| | Piperidines | 1 | 2000 | 162 | 0.040 |
Why?
| | Heparin | 1 | 2000 | 222 | 0.040 |
Why?
| | Muscle Strength | 2 | 2013 | 271 | 0.040 |
Why?
| | Hyperplasia | 1 | 2019 | 165 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 372 | 0.040 |
Why?
| | Gain of Function Mutation | 1 | 2018 | 31 | 0.040 |
Why?
| | Biomarkers, Tumor | 2 | 2018 | 1045 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2009 | 1879 | 0.040 |
Why?
| | Immunization | 1 | 2001 | 400 | 0.040 |
Why?
| | Pancreatic Elastase | 1 | 2018 | 67 | 0.040 |
Why?
| | Sputum | 1 | 2020 | 285 | 0.040 |
Why?
| | Sri Lanka | 1 | 2018 | 7 | 0.040 |
Why?
| | Larva | 1 | 2019 | 193 | 0.040 |
Why?
| | Interleukin-4 | 1 | 2019 | 209 | 0.040 |
Why?
| | Intestines | 1 | 2021 | 322 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 487 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2001 | 1229 | 0.040 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2019 | 139 | 0.040 |
Why?
| | Body Composition | 2 | 2013 | 586 | 0.040 |
Why?
| | Immunologic Techniques | 1 | 1997 | 39 | 0.040 |
Why?
| | Lipids | 1 | 2021 | 586 | 0.040 |
Why?
| | RNA Transport | 1 | 2017 | 22 | 0.040 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 11 | 0.040 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 151 | 0.040 |
Why?
| | Chemokines | 2 | 2009 | 213 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 719 | 0.040 |
Why?
| | Biopsy | 1 | 2001 | 1046 | 0.040 |
Why?
| | Antigens, Ly | 1 | 2017 | 45 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 88 | 0.040 |
Why?
| | Aged | 5 | 2015 | 19119 | 0.040 |
Why?
| | CpG Islands | 1 | 2017 | 118 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 128 | 0.040 |
Why?
| | Acetylcholine | 1 | 1997 | 179 | 0.040 |
Why?
| | Thermodynamics | 2 | 2009 | 383 | 0.040 |
Why?
| | NF-kappa B | 2 | 2012 | 637 | 0.030 |
Why?
| | Epithelial Sodium Channels | 1 | 2016 | 12 | 0.030 |
Why?
| | Rabbits | 1 | 1997 | 750 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2015 | 3015 | 0.030 |
Why?
| | ADAMTS9 Protein | 1 | 2015 | 6 | 0.030 |
Why?
| | Serpin E2 | 1 | 2015 | 6 | 0.030 |
Why?
| | Procollagen N-Endopeptidase | 1 | 2015 | 8 | 0.030 |
Why?
| | ADAMTS4 Protein | 1 | 2015 | 15 | 0.030 |
Why?
| | Child | 3 | 2021 | 18407 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 280 | 0.030 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2015 | 29 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 53 | 0.030 |
Why?
| | Serpins | 1 | 2015 | 26 | 0.030 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2015 | 14 | 0.030 |
Why?
| | ADAM Proteins | 1 | 2015 | 58 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 225 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 1857 | 0.030 |
Why?
| | Mucin-4 | 1 | 2014 | 3 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 541 | 0.030 |
Why?
| | Child, Preschool | 2 | 2021 | 9093 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 191 | 0.030 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 53 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2017 | 284 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 924 | 0.030 |
Why?
| | Monocytes | 1 | 2017 | 503 | 0.030 |
Why?
| | Pneumonia, Bacterial | 1 | 2015 | 106 | 0.030 |
Why?
| | Binding Sites | 1 | 2017 | 1173 | 0.030 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 249 | 0.030 |
Why?
| | Immunophenotyping | 1 | 2014 | 276 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 817 | 0.030 |
Why?
| | Nanoparticles | 1 | 2017 | 313 | 0.030 |
Why?
| | Administration, Inhalation | 1 | 2015 | 641 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2012 | 3896 | 0.030 |
Why?
| | Musculoskeletal Physiological Phenomena | 1 | 2013 | 8 | 0.030 |
Why?
| | Whole Body Imaging | 1 | 2013 | 23 | 0.030 |
Why?
| | DNA Methylation | 1 | 2017 | 496 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 999 | 0.030 |
Why?
| | Passive Cutaneous Anaphylaxis | 1 | 2012 | 5 | 0.030 |
Why?
| | E-Box Elements | 1 | 2012 | 4 | 0.030 |
Why?
| | Ligands | 1 | 2014 | 565 | 0.030 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2012 | 29 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2012 | 133 | 0.030 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 129 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2012 | 137 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2013 | 223 | 0.030 |
Why?
| | Macromolecular Substances | 1 | 2012 | 200 | 0.030 |
Why?
| | Cell Separation | 1 | 2013 | 291 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 398 | 0.020 |
Why?
| | Bronchoconstrictor Agents | 1 | 2011 | 14 | 0.020 |
Why?
| | Cecum | 1 | 2011 | 32 | 0.020 |
Why?
| | Arthropod Proteins | 1 | 2011 | 4 | 0.020 |
Why?
| | Particle Size | 1 | 2012 | 317 | 0.020 |
Why?
| | Muscle Proteins | 1 | 2013 | 210 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 356 | 0.020 |
Why?
| | Airway Resistance | 1 | 2011 | 33 | 0.020 |
Why?
| | Resistance Training | 1 | 2013 | 113 | 0.020 |
Why?
| | Cysteine Endopeptidases | 1 | 2011 | 60 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 797 | 0.020 |
Why?
| | Materials Testing | 1 | 2012 | 339 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2012 | 447 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2341 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2014 | 696 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3334 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 876 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2011 | 245 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 872 | 0.020 |
Why?
| | Habits | 1 | 2010 | 37 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1375 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1149 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2011 | 297 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1780 | 0.020 |
Why?
| | Tumor Burden | 1 | 2010 | 260 | 0.020 |
Why?
| | Speech | 1 | 2010 | 68 | 0.020 |
Why?
| | Cell Degranulation | 1 | 2009 | 39 | 0.020 |
Why?
| | Survival | 1 | 2009 | 37 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1084 | 0.020 |
Why?
| | Body Height | 1 | 2010 | 180 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2011 | 323 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2015 | 1085 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2011 | 192 | 0.020 |
Why?
| | Physical Exertion | 1 | 2010 | 211 | 0.020 |
Why?
| | Physical Fitness | 1 | 2010 | 179 | 0.020 |
Why?
| | Molecular Weight | 1 | 2009 | 331 | 0.020 |
Why?
| | Proteomics | 1 | 2014 | 844 | 0.020 |
Why?
| | Antigens, Bacterial | 1 | 2009 | 112 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2013 | 1664 | 0.020 |
Why?
| | Leg | 1 | 2010 | 227 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2009 | 98 | 0.020 |
Why?
| | Ozone | 1 | 2009 | 99 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2008 | 76 | 0.020 |
Why?
| | Uridine Triphosphate | 1 | 2008 | 11 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2008 | 140 | 0.020 |
Why?
| | Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 19 | 0.020 |
Why?
| | Neovascularization, Physiologic | 1 | 2009 | 173 | 0.020 |
Why?
| | Colony Count, Microbial | 1 | 2008 | 111 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2008 | 80 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2011 | 723 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2010 | 588 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 437 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2008 | 257 | 0.020 |
Why?
| | Exons | 1 | 2008 | 301 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2009 | 282 | 0.020 |
Why?
| | Gene Silencing | 1 | 2008 | 172 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 778 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 776 | 0.020 |
Why?
| | Survival Rate | 1 | 2010 | 1646 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2008 | 196 | 0.020 |
Why?
| | Cell Survival | 1 | 2009 | 1022 | 0.020 |
Why?
| | Cell Shape | 1 | 2006 | 54 | 0.020 |
Why?
| | Body Weight | 1 | 2010 | 873 | 0.020 |
Why?
| | Receptors, Interleukin-4 | 1 | 2005 | 15 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2008 | 349 | 0.020 |
Why?
| | Receptors, CCR3 | 1 | 2005 | 8 | 0.020 |
Why?
| | Chemokine CCL11 | 1 | 2005 | 22 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 331 | 0.020 |
Why?
| | Parasympathetic Nervous System | 1 | 2005 | 25 | 0.020 |
Why?
| | Motor Activity | 1 | 2010 | 642 | 0.020 |
Why?
| | Models, Genetic | 1 | 2008 | 566 | 0.020 |
Why?
| | Alleles | 1 | 2008 | 792 | 0.020 |
Why?
| | Chronic Disease | 1 | 2011 | 1591 | 0.020 |
Why?
| | History, 20th Century | 1 | 2006 | 267 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2007 | 616 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2011 | 1203 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2015 | 5040 | 0.010 |
Why?
| | Rats | 1 | 2012 | 4973 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2009 | 685 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 10498 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2007 | 1138 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1144 | 0.010 |
Why?
| | Disease Progression | 1 | 2009 | 2389 | 0.010 |
Why?
| | Infant | 1 | 2015 | 7945 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2008 | 1019 | 0.010 |
Why?
| | Diamines | 1 | 1999 | 3 | 0.010 |
Why?
| | Integrin alpha4beta1 | 1 | 1999 | 6 | 0.010 |
Why?
| | Muscarinic Agonists | 1 | 1999 | 9 | 0.010 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 1999 | 15 | 0.010 |
Why?
| | Atropine | 1 | 1999 | 31 | 0.010 |
Why?
| | Vagotomy | 1 | 1999 | 34 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 6357 | 0.010 |
Why?
| | Muscarinic Antagonists | 1 | 1999 | 26 | 0.010 |
Why?
| | Integrins | 1 | 1999 | 79 | 0.010 |
Why?
| | Pregnancy | 1 | 2009 | 5519 | 0.010 |
Why?
|
|
Evans's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|